MINI FUTURE LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000MB96Q83

Real-time Bid/Ask 10:52:55 03/06/2024 pm IST
8.05 EUR / 8.1 EUR +8.39% Intraday chart for MINI FUTURE LONG - BECTON DICKINSON AND CO.
1 month-7.11%
3 months-9.04%
Date Price Change
03/24/03 8.11 +8.86%
31/24/31 7.45 +6.28%
30/24/30 7.01 +0.29%
29/24/29 6.99 -1.27%
28/24/28 7.08 -2.07%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 07:23 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MB96Q8
ISINDE000MB96Q83
Date issued 26/07/2023
Strike 150.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 12.64
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.3
Lowest since issue 6.64
Spread 0.05
Spread %0.62%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus